These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26091495)

  • 1. [Incentives of German Rehabilitation Centers to Implement Screening Strategies for the Prevention of Methicillin-resistant Staphylococcus aureus (MRSA) Transmissions and Infections].
    Claus F; Ried W
    Rehabilitation (Stuttg); 2015 Jun; 54(3):198-204. PubMed ID: 26091495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of universal MRSA screening on admission to surgery.
    Murthy A; De Angelis G; Pittet D; Schrenzel J; Uckay I; Harbarth S
    Clin Microbiol Infect; 2010 Dec; 16(12):1747-53. PubMed ID: 20331684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness and cost benefit of universal versus targeted methicillin-resistant Staphylococcus aureus screening upon admission in hospitals.
    Leonhardt KK; Yakusheva O; Phelan D; Reeths A; Hosterman T; Bonin D; Costello M
    Infect Control Hosp Epidemiol; 2011 Aug; 32(8):797-803. PubMed ID: 21768764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers.
    McKinnell JA; Bartsch SM; Lee BY; Huang SS; Miller LG
    Infect Control Hosp Epidemiol; 2015 Jan; 36(1):2-13. PubMed ID: 25627755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for cost reduction based on pre-admission MRSA screening in general surgery.
    Diller R; Sonntag AK; Mellmann A; Grevener K; Senninger N; Kipp F; Friedrich AW
    Int J Hyg Environ Health; 2008 Mar; 211(1-2):205-12. PubMed ID: 17692566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost comparison of MRSA screening and management - a decision tree analysis.
    Tübbicke A; Hübner C; Hübner NO; Wegner C; Kramer A; Fleßa S
    BMC Health Serv Res; 2012 Dec; 12():438. PubMed ID: 23198880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The MRSA patient in technical orthopaedics and rehabilitation. Part 2: Hygiene management].
    Hornberg C; Schäfer TR; Koller A; Wetz HH
    Orthopade; 2003 Mar; 32(3):218-24. PubMed ID: 12647043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methicillin-resistant Staphylococcus aureus (MRSA) in medical rehabilitation. Draft of a model hygiene plan].
    Hergenröder H; Mielke M; Höller C; Herr C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Nov; 55(11-12):1453-64. PubMed ID: 23114445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multidrug-Resistant Organisms (MDRO) in Rehabilitation Clinics in the Rhine-Main District, Germany, 2014: Risk Analysis and Hygiene Procedures].
    Heudorf U; Färber D; Mischler D; Schade M; Zinn C; Nillius D; Herrmann M
    Rehabilitation (Stuttg); 2015 Dec; 54(6):375-81. PubMed ID: 26676735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of outpatient and inpatient MRSA screening and treatment strategies for patients at elective hospital admission - a decision tree analysis.
    Hutzschenreuter L; Flessa S; Dittmann K; Hübner NO
    Antimicrob Resist Infect Control; 2018; 7():147. PubMed ID: 30519461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of a "search and destroy" strategy for the prevention of methicillin-resistant Staphylococcus aureus infections in an inpatient rehabilitation facility.
    Widner A; Nobles DL; Faulk C; Vos P; Ramsey KM
    PM R; 2014 Feb; 6(2):121-6; quiz 126. PubMed ID: 24107426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hand hygiene noncompliance and the cost of hospital-acquired methicillin-resistant Staphylococcus aureus infection.
    Cummings KL; Anderson DJ; Kaye KS
    Infect Control Hosp Epidemiol; 2010 Apr; 31(4):357-64. PubMed ID: 20184440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost/benefit calculations of meticillin-resistant Staphylococcus aureus screening methods and their practical importance].
    Knausz M; Kaproncai G; Rozgonyi F
    Orv Hetil; 2010 May; 151(22):893-8. PubMed ID: 20478810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost and effects of different admission screening strategies to control the spread of methicillin-resistant Staphylococcus aureus.
    Gurieva T; Bootsma MC; Bonten MJ
    PLoS Comput Biol; 2013; 9(2):e1002874. PubMed ID: 23436984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective?
    Papia G; Louie M; Tralla A; Johnson C; Collins V; Simor AE
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):473-7. PubMed ID: 10432159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Costs associated with multiresistant bacteria in neurorehabilitation].
    Roukens R; Lauster F; Bara M; Eifert B; Willemsen D; Randall T; Herzog J; Wendt C; Schmidt-Wilcke T; Knecht S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Oct; 60(10):1075-1082. PubMed ID: 28812106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands.
    Vos MC; Behrendt MD; Melles DC; Mollema FP; de Groot W; Parlevliet G; Ott A; Horst-Kreft D; van Belkum A; Verbrugh HA
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):977-84. PubMed ID: 19712031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus.
    Lee BY; Wiringa AE; Bailey RR; Goyal V; Tsui B; Lewis GJ; Muder RR; Harrison LH
    Infect Control Hosp Epidemiol; 2010 Nov; 31(11):1130-8. PubMed ID: 20923285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment.
    Wernitz MH; Keck S; Swidsinski S; Schulz S; Veit SK
    Clin Microbiol Infect; 2005 Jun; 11(6):466-71. PubMed ID: 15882196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Economic aspects of the management and control of MRSA].
    Hübner NO; Hübner C; Kramer A
    Gesundheitswesen; 2009 Nov; 71(11):771-6. PubMed ID: 19937566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.